The S&P 500 declined 0.55% yesterday on decelerating volume.  Yesterday’s theme seemed to focus on the fact that sovereign debt issues will not go away.  While the European Commission backing of Greece's deficit reduction plan may have put that country concerns on the back burner, sovereign credit concerns shifted to Spain and Portugal.  As a result there was a pick up in the RISK AVERSION trade.  The dollar Index was up 0.45% yesterday and VIX was marginally higher too. 


The Hedgeye Risk Management models have the following levels for VIX – buy Trade (20.70) and Sell Trade (22.23). 


Given the sovereign debt issues, we do not want to be net long Latin America (Brazil), and as a result we shorted Mexico.  Mexico short is a solid compliment to our short position on oil and our concerns about sovereign debt risks.  The Hedgeye Risk Management models have the following levels for DXY – buy Trade (78.01) and sell Trade (79.73). 


On the MACRO front the ISM non-manufacturing index rose to 50.5 in January from 49.8 in December. However, the headline reading came in below the 51 consensus.  The data highlighted the extent to which the services sector continues to lag the recovery in manufacturing.  This was made clear in the employment component, which increased to 44.6 from 43.6, a slowing rate of improvement. 


Also on the MACRO front the ADP employment fell 22K in January vs. consensus expectations for a drop of 30K, marking the smallest decline since January 2008.


Yesterday, the worst performing sector was Healthcare (XLV); the XLV also broke TRADE.  The earnings miss from Pfizer (PFE) and scaled back financial targets for 2012 was not received well.  The managed care group also came under pressure with the HMO’s down 1.6% following reports that House Democrats plan to revive a small piece of their healthcare reform agenda that would repeal the HMO antitrust exemption.


The Financials (XLF) was one of the worst performing sectors yesterday.  While the insurance space was in focus following a number of earnings reports, the banking group provided a meaningful headwind with the BKX index down 2.4%.  The regional’s remained on the defensive amid concerns about the extent of their run-up on the back of the largely favorable takeaways from Q4 results.  Money center names held up better on the day, as the group has been a beneficiary of recent thoughts that regulatory concerns may be overdone.


Consumer Discretionary (XLY) was one of two sectors that finished up on the day.  Media names were a big driver of the strength following better-than-expected December quarter earnings.  MCD also outperformed after the stock was added to the Conviction Buy List at Goldman, while YUM was down 1.3% before it reported mixed results after the close. 


As we look at today’s set up the range for the S&P 500 is 33 points or 2.0% (1,075) downside and 1.0% (1,108) upside.  Equity futures are trading below fair value following yesterday's decline.  Earnings remain in focus and markets may try to draw some benefit from Cisco System's (CSCO) Q2 earnings reported after the close.


In early trading Copper looks to be headed lower for the 2nd day in a row.  The Hedgeye Risk Management Quant models have the following levels for COPPER – Buy Trade (2.89) and Sell Trade (3.14).


In early trading Gold also looks to be lower on the strength in the dollar index.  The Hedgeye Risk Management models have the following levels for GOLD – Buy Trade (1,076) and Sell Trade (1,113).


Crude oil is headed lower on inventory gains and a stronger dollar.  The Hedgeye Risk Management models have the following levels for OIL – Buy Trade (72.04) and Sell Trade (78.32).  We remain short the US Oil Fund (USO).


Howard Penney

Managing Director
















While Q4 consensus has come down, it may not be enough. The stock has fared poorly (down almost 30% since late November) so a miss is probably discounted to some extent.



PNK reports Q4 EPS tomorrow morning.  In projecting an Adjusted EPS loss of $0.13, we are below the Street consensus at ($0.08). Our Adjusted EBITDA estimate of $37.1 million compares to the Street at $40.3 million.  Louisiana, which has held up so well during most of this downturn, has been in a tailspin.  Total EBITDA from the state could fall over 30% from last year.  Recovery here is likely to take longer than the rest of the regional markets and will depress PNK’s profits for much of 2010.  Remember that 60-70% of PNK’s property EBITDA is generated in Louisiana.


The following “Youtube” highlights management’s forward looking commentary from the Q3 earnings release and conference call.





Property specific

  • “Residents from New Orleans have seen a significant increase in marketing from casinos along the Mississippi Gulf Coast, and that has in turn affected our business at Boomtown. The good news is that with October now largely complete, it appears that revenues have stabilized at Boomtown New Orleans. With revenues now stable, we'll use the remainder of the year to focus on bringing margins back up at the property.”
    • I assume he meant stabile relative to 3Q trends because in the 4th quarter state reported gross gaming revenues for the property declined 13.4% vs. an 11.6% decline in Q3
  • “In Reno, according to the monthly revenue statistics put out by the state, the entire Reno market continued to see declines in gaming revenues during the 2009 third quarter, caused by both additional Native American casinos in Northern California and general economic conditions. We were not immune to that trend. Based on recent trends, however, it does appear that gaming revenues are starting to stabilize for Boomtown Reno.  We hope to get profitable over the next, let's say 12 months going forward and hopefully improve from there.”
  • “I think the major single factor other than the economy that affected New Orleans was competition from the Mississippi Gulf Coast, which is not very far away. As they try to figure out how to keep their hotels built, since they weren't getting people from Florida or Atlanta anymore, they just reached out for people that are in our way.”
  • “What did happen in Lake Charles was Delta Downs got very aggressive with their promotions earlier this year. They took some market share from us. We got more aggressive in the recent quarter and I think we've got our market share back,that hurt our margins a little bit. So we've had a little bit of a promotions battle going on between us Delta Downs, we're twice their size, more than twice their size. And I think we'll continue to show good results at L'Auberge as we have.”
  • “If we never open River City, I think you continue to see strong growth with Lumière Place but obviously, River City will take a bite out of that. And we think between the two, we'll do at maturity, $120 million, $130 million a year EBITDA and maturity might be a couple of years away because of some disruption when we first opened.”
  • L’Auberge margins:  “I think it may take a couple of quarters for us to get the margins back up. We'll eventually get up there, I don't know if it will be the fourth quarter or not.”
  • L’Auberge: “so October was at a pace of third quarter, but we're more optimistic on November and December.”
    • Unfortunately, Nov & Dec gross gaming numbers were down 22% and 24% y-o-y, respectively
  • “I think we're on a positive trend in New Orleans. I think we're just starting a positive trend now at L'Auberge.”


Development update

  • “River City continues to move along on time and the same basis of budget that we previously outlined, the cash portion of that budget continues to be $357 million, of which we spent to date, $228 million approximately. And the timing of the project is expected to open in the spring of 2010 and we feel very good about the prospects of that property upon opening next year.”
    • On December 14th, PNK announced that the opening would be accelerated to March 2010
  • “Sugarcane Bay, we started driving piles earlier this month to put in the foundation for the project. The project that actually started last year when we started doing the road that expanded. The visibility of our property and access at L'Auberge and that would also be the road to Sugarcane Bay. With the project budget is the cash basis at $391 million, we expect to be on that pace and progress on that project as we move on through the fourth quarter and into next year.”
    • On Nov 24th the project's budget was updated to “approximately $305 million, excluding capitalized interest, and includes approximately $54 million spent to date” and noted that  completion is expected “ in late 2010 and open the hotel and related amenities in the first half of 2011”
  • Baton Rouge: “We will start construction of that project promptly after the approval of the contracts, which we would expect will happen in May of next year.”
    • On Nov 24th PNK announced that it “is proceeding with plans for its casino project in Baton Rouge, Louisiana, which represents an investment of approximately $260 million, excluding capitalized interest. As announced previously, the Baton Rouge project will include a new, single-level riverboat with an expansive casino; a 100-room hotel; an exciting mix of restaurants and lounges; and an entertainment venue.”
  • “Regards to CapEx, we expect Sugarcane Bay next year to grow somewhere around $225 million in a cash basis, excluding cap interest. And go through the rest, Baton Rouge, that number is somewhere near $60 million and you have 40 or so maintenance CapEx across the portfolio.”  I assume this will change with the revised budgets
  • “We hope both Sugarcane Bay and Baton Rouge do about a 15% cash-on-cash return.  That's 15% on the $400 million investment. And so that'd be an incremental $60 million of EBITDA above the 80 or 90 is doing now. The run rate I think is about 85, so...”

Early Look

daily macro intelligence

Relied upon by big institutional and individual investors across the world, this granular morning newsletter distills the latest and most vital market developments and insures that you are always in the know.


CKR reported period 13 and fiscal 4Q10 blended same-store sales today of -6.4% and -6.0%, respectively.  The biggest challenge continues to be at Carl’s Jr., which reported a 9.0% comparable store sales decline for period 13.  Although this -9% number is a 65 bp improvement from period 12 on a 2-year average basis, the full fourth quarter result of -8.7% implies 230 bps of deterioration from 3Q10.  Hardee’s same-store sales decreased 2.8% during period 13, which marked a significant fall off from the prior period with 2-year average trends declining more than 100 bps on a sequential basis. 


The company attributed weakness at both concepts to continued high levels of unemployment, “deep-discount burger wars” and weather.  Specifically, CKR’s CEO Andrew Puzder said, “Both brands' sales results were also significantly impacted by worse weather this year than in the prior year. Carl's Jr., experienced severe rain in its core West Coast markets for most of the final week of the period and Hardee's experienced severe winter weather in several of its core mid-west and southeast markets.”


Despite the impact of weather, CKR’s full year 2010 3.9% blended same-store sales decline came in at the lower end of management's guidance of -3.5% to -4.0%.  Management also reiterated its prior full-year outlook for a 20 to 40 bp decline in restaurant level margin, but provided 4Q10 guidance of 16% to 16.3%, which implies full year numbers will come in toward the lower end of the range.  Relative to fiscal 4Q09’s 18% restaurant margin, this guidance assumes that margins will decline 170 to 200 bps YOY, reversing the prior three quarters of margin growth despite the decline in top-line trends.  We have been saying that it was only a matter of time before gravity would set in. 


During the fourth quarter, management expects about 40 to 50 bps of YOY food and packaging cost favorability to be offset by sales deleveraging on both the labor and occupancy expense lines.  Food cost favorability has helped to stave off margin declines earlier in the year despite the significant demand headwinds with food and packaging costs as a percentage of sales declining 60 bps YOY in Q1, 140 bps in Q2 and 180 bps in Q3.  CKR will begin to lap this benefit in the first quarter of fiscal 2011, making it increasingly more difficult to hold the line on margins.  And as 4Q10 guidance makes clear, even with food costs providing a tailwind in the quarter, margins cannot continue to move higher with blended same-store sales  down 6%.



Howard Penney

Managing Director







Capital Markets Risk Management: Biotech IPO's

While Healthcare and Biotech Capital Raises have had a historic run through the back half of 2009, the IPO calendar, particularly for speculative biotech, has been notably light.


In yesterday’s morning note we suggested you keep the pricing of the Ironwood Pharmaceuticals IPO on your radar as a potential lead indicator for CRO’s and measure of remaining risk appetite as market momentum & sentiment have rolled in the past couple weeks.  The offering, which was expected to price 16.7M shares at $14-16, ended up pricing at $11.25/share – a 30% haircut and the biggest reduction for a U.S. IPO YTD.


The pricing of IRWD is an extension of the 2009 trend in U.S. Healthcare IPO’s which were both infrequent and uninspiring.  Of the nine Healthcare IPO’s debuting in 2009, six have turned in negative absolute performance while underperforming both the XLV and the S&P500. 


Coming out of the 2001 recession, Biotech IPO’s didn’t see a meaningful, more sustained uptick until 4Q2003.  While the deluge of offerings in the 2000, pre-recession period likely exacerbated the drought in the post recession period it's at least noteworthy to point out the lag between the recovery of the market and ^NBI Index and the recovery in the IPO market.  Presently, the success or failure of Ironwood may serve as a Go or No-Go signal for the IPO market and the growing list of prospective offerings backed up in the pipeline.  


Biotech has been on a tear of late, capital raising has continued unabated, and a successful return of the IPO market would serve as an important confirmationary indicator of resurgent investor interest and pending capital investment to the industry. The outcome here holds important consequences for Drug Development Service companies who need biotech allocations to drive growth as the Large Pharma outsource story loses juice.     


IRWD shares were set to begin trading at 11am and we’d like see at least 3 days of volume & price action before vetting the result.  Our next look at the health of the IPO market may come compliments of Anthera Pharmaceuticals who, notably, amended their S-1 this morning to reduce the size of the intended offering.    


Christian B. Drake



Capital Markets Risk Management: Biotech IPO's - US HC IPO Performance


Capital Markets Risk Management: Biotech IPO's - U.S. Biotech HC IPO s



real-time alerts

real edge in real-time

This indispensable trading tool is based on a risk management signaling process Hedgeye CEO Keith McCullough developed during his years as a hedge fund manager and continues to refine. Nearly every trading day, you’ll receive Keith’s latest signals - buy, sell, short or cover.